9.05 USD
↘ 0.21 (2.27%)AT CLOSE (03:59 PM EDT)
AgomAb Therapeutics NV American Depositary Shares
AGMBNASDAQ • USD
9.01
↘ 0.04 (0.45%)
POST MARKET (AS OF 08:00 PM EDT)
Post Market
AS OF 08:00 PM EDT
9.01
↘ 0.04 (0.45%)
Market: CLOSED
AGMB is currently priced at $9.05. The technical outlook is "Sell" based on moving average alignment, RSI, and MACD signals. Key drivers include a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.
Technical & fundamental data as of Oct 23, 2026.
Open?$9.15
High?$9.18
Low?$8.57
Prev. Close?$9.26
Volume?51.2K
Avg. Volume?N/A
VWAP?$9.08
Bid / Ask
Bid?$7.00 × 100
Ask?$11.31 × 100
Spread?$4.31
Midpoint?$9.16
Valuation & Ratios
Market Cap?456.0M
Shares Out?N/A
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Its product candidates are designed to target established pathways and utilize validated modalities, with a focus on addressing limitations associated with prior treatment approaches. The company's pipeline includes small molecule and antibody product candidates aimed at targets associated with fibrotic diseases. Key candidates include Ontunisertib (AGMB-129) and AGMB-447.
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestHigh
Short Interest?1.0M
Days to Cover?7.1
Avg Daily Volume140.7K
Settlement Date2026-09-30